Piramal Critical Care, an integral business unit of Piramal | Healthcare is a global leader in the field of anesthesia. With a varied range of anesthesia solutions, both inhaled & intravenous, Piramal Critical Care aims at providing a better access to critical care products across the world.
Piramal Critical Care has product availability in more than 113 countries and is globally renowned in the domain of critical care. We are the world’s third largest producers of inhaled anesthetics and are widely present across Europe and the USA. Our consistent efforts and commitment towards the critical care fraternity has helped us quickly expand horizons and gain prominence in other markets across the globe.
Our rich product portfolio includes inhalation anesthetics such as Halothane, Isoflurane and Sevoflurane. Other critical care products such as Propofol and plasma volume expanders such as Polygeline also form a part of our offerings.
Piramal Critical Care has an excellent record of managing collaborative ventures and mergers. Much of our
growth has come through acquisitions involving long-established manufacturers of well-known, trusted products. The Critical Care division came into being in 2002 with the acquisition of ICI India Ltd. followed by a string of other acquisitions like:
- 2005: Acquisition of Inhalation Anesthetic business of Rhodia Organique Ltd, UK
- 2008: Acquisition of brand Haemaccel from Pharmaselect, Germany
- 2009: Acquisition of RxElite Inc., USA
- 2009: Acquisition of Minrad Inc., USA
- 2010: Acquisition of business Unit AltaSelect S.r.l.
Our commitment for quality is resonated in global regulatory approvals that are accredited to our manufacturing plants. Our state-of-the-art manufacturing facilities in Bethlehem (USA) and Digwal (India), ensure adherence to world-class standards. The strategic location of these plants enables us to supply products throughout the length and breadth of the world with great amount of flexibility and helps us adhere to our commitment towards uninterrupted delivery.
“Save lives with critical care solutions” is much more than a purpose statement for us.
At Piramal Critical Care, we constantly help in improvement and betterment of the anesthesia fraternity. We are on a constant endeavour to find out the real needs of the patients and providers. An expert team of scientists at our R&D facility are dedicated towards developing innovative drug delivery mechanisms and new generation critical care products.
Our strength lies in our culturally diversified team of 350 members from 20 nationalities, based out of 15 countries world over, with major operations in the USA.